{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:00:01Z","timestamp":1785308401785,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"\n Background<\/jats:title>\n Vancomycin trough concentration (VTC) is commonly monitored to guide therapy in severe infections, yet its association with acute kidney injury (AKI) in septic patients remains inadequately characterized, particularly regarding the shape of the dose-response relationship and potential effect modifiers. This study aimed to investigate the relationship between initial VTC and AKI risk in sepsis, and to identify whether this association is modified by key clinical subgroups.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a multicenter retrospective cohort study using the multicenter eICU Collaborative Research Database. Adults with sepsis who received intravenous vancomycin and had an initial trough concentration (VTC) measured were included; patients with acute kidney injury (AKI) diagnosed before the initial VTC measurement were excluded. The primary outcome was AKI during ICU stay, defined by KDIGO creatinine criteria. Multivariable logistic regression, generalized additive models, and subgroup analyses were used to evaluate the association between initial VTC and AKI, testing for interactions with prespecified covariates. Aminoglycoside use was rare (n = 3, 0.3%) and was therefore not included in the analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 946 eligible patients, the overall AKI incidence was 9.7%. After multivariable adjustment, each 1\u00a0mg\/L increase in initial VTC was associated with 6% higher odds of AKI (adjusted OR 1.06, 95% CI 1.02\u20131.11,\n P<\/jats:italic>\n = 0.002). Patients with VTC &gt;20\u00a0mg\/L had a 3.5-fold higher risk compared with those with VTC \u226410\u00a0mg\/L. The dose-response relationship was approximately linear (edf = 1.00,\n P<\/jats:italic>\n = 0.002), with limited evidence for a distinct threshold. A significant interaction was observed for lactate level (\n P<\/jats:italic>\n for interaction = 0.025): in patients with lactate &gt;2.0\u00a0mmol\/L, each 1\u00a0mg\/L increase in VTC was associated with a 13% higher odds of AKI (aOR 1.13, 95% CI 1.05\u20131.21,\n P<\/jats:italic>\n = 0.001), whereas no significant association was found in those with lactate \u22642.0\u00a0mmol\/L (aOR 1.03, 95% CI 0.98\u20131.08,\n P<\/jats:italic>\n = 0.258).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In septic patients, higher initial VTC is independently and linearly associated with increased AKI risk without a discrete safety threshold. This association is significantly stronger in patients with hyperlactatemia, generating the hypothesis that lactate level identifies a subgroup with heightened susceptibility to vancomycin-associated nephrotoxicity, which requires prospective validation.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fphar.2026.1817481","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:31Z","timestamp":1785305011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Linear dose-response relationship between vancomycin trough concentration and acute kidney injury in sepsis: effect modification by hyperlactatemia"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Pangang Group General Hospital","place":["Panzhihua, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Pangang Group General Hospital","place":["Panzhihua, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pangang Group General Hospital","place":["Panzhihua, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pangang Group General Hospital","place":["Panzhihua, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanchong Central Hospital","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Pangang Group General Hospital","place":["Panzhihua, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/antibiotics12091441","article-title":"The significance of Bayesian pharmacokinetics in dosing for critically ill patients: a primer for Clinicians using vancomycin as an example","volume":"12","author":"Alnezary","year":"2023","journal-title":"Antibiot. (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1473-3099(23)00432-2","article-title":"Understanding vancomycin nephrotoxicity augmented by \u03b2-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and \u03b2-lactam chemistry","volume":"24","author":"Alosaimy","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","article-title":"Optimizing the clinical use of vancomycin","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1389140","DOI":"10.3389\/fphar.2024.1389140","article-title":"Development and validation of a nomogram to predict the risk of vancomycin-related acute kidney injury in critical care patients","volume":"15","author":"Bao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e14025","DOI":"10.1111\/apha.14025","article-title":"Renal arterial infusion of tempol prevents medullary hypoperfusion, hypoxia, and acute kidney injury in ovine Gram-negative sepsis","volume":"239","author":"Betrie","year":"2023","journal-title":"Acta Physiol. (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"106960","DOI":"10.1016\/j.toxicon.2022.106960","article-title":"Megalin blockade with cilastatin ameliorates multiple wasp sting-induced acute kidney injury in rats","volume":"220","author":"Han","year":"2022","journal-title":"Toxicon"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00228-019-02694-1","article-title":"Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?","volume":"75","author":"Heffernan","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/14740338.2024.2393285","article-title":"Risk factors analysis and construction of predictive models for acute kidney injury in overweight patients receiving vancomycin treatment","volume":"24","author":"Hong","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"B9","doi-asserted-by":"publisher","first-page":"690157","DOI":"10.3389\/fphar.2021.690157","article-title":"Relationship between mean vancomycin trough concentration and mortality in critically ill patients: a multicenter retrospective study","volume":"12","author":"Hou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.7150\/thno.122991","article-title":"H3K18 lactylation-mediated SPHK1-SIRT1 feedback loop accelerates pyroptosis of tubular epithelial cells in sepsis-associated acute kidney injury","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.jtha.2024.02.006","article-title":"The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy","volume":"22","author":"Iba","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e6023","DOI":"10.1097\/MD.0000000000006023","article-title":"Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: a retrospective cohort study","volume":"96","author":"Lacave","year":"2017","journal-title":"Med. Baltim."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.3390\/ijms221810111","article-title":"Metabolic and lipidomic assessment of kidney cells exposed to nephrotoxic vancomycin dosages","volume":"22","author":"Lagies","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2411943","DOI":"10.1002\/advs.202411943","article-title":"Aldehyde dehydrogenase 2 lactylation aggravates mitochondrial dysfunction by disrupting PHB2 mediated mitophagy in acute kidney injury","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e01033-17","DOI":"10.1128\/AAC.01249-17","article-title":"Influence of mechanical ventilation on the pharmacokinetics of vancomycin administered by continuous infusion in critically ill patients","volume":"61","author":"Medell\u00edn-Garibay","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"180178","DOI":"10.1038\/sdata.2018.178","article-title":"The eICU collaborative research database, a freely available multi-center database for critical care research","volume":"5","author":"Pollard","year":"2018","journal-title":"Sci. Data"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1710624","DOI":"10.3389\/fimmu.2026.1710624","article-title":"Inflammation, cell death, and lncRNAs: unraveling the mechanisms of sepsis-associated acute kidney injury","volume":"17","author":"Ren","year":"2026","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases society of America, the American society of health-system pharmacists, and the society of infectious diseases pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American society of health-system pharmacists, the infectious diseases society of America, the pediatric infectious diseases society, and the society of infectious diseases pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"729209","DOI":"10.3389\/fimmu.2021.729209","article-title":"Extracellular lactate acts as a metabolic checkpoint and shapes monocyte function time dependently","volume":"12","author":"Schenz","year":"2021","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1378\/chest.15-1703","article-title":"Lactic acidosis in sepsis: it's not all anaerobic: implications for diagnosis and management","volume":"149","author":"Suetrong","year":"2016","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"114202","DOI":"10.1016\/j.biopha.2022.114202","article-title":"Immunoregulatory mechanism of acute kidney injury in sepsis: a narrative review","volume":"159","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1053754","DOI":"10.3389\/fimmu.2022.1053754","article-title":"CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/antibiotics13060497","article-title":"Is it still beneficial to monitor the trough concentration of vancomycin? A quantitative meta-analysis of nephrotoxicity and efficacy","volume":"13","author":"Yang","year":"2024","journal-title":"Antibiot. (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/antibiotics11010112","article-title":"The serum concentration of vancomycin as a diagnostic predictor of nephrotoxic acute kidney injury in critically ill patients","volume":"11","author":"Zamoner","year":"2022","journal-title":"Antibiot. (Basel)."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1817481\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:32Z","timestamp":1785305012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1817481\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":29,"alternative-id":["10.3389\/fphar.2026.1817481"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1817481","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1817481"}}